Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation

Recruiting now · Not applicable

Conditions studied: Parkinson Desease

In brief

This randomized controlled trial aims to compare the effectiveness of a Collaborative Virtual Reality Environment (CVE) and Non-Immersive Virtual Reality (NIVR) in the rehabilitation of patients with Parkinson's disease. Participants with mild to moderate disease severity will be randomly assigned to either the CVE group or the NIVR group. The CVE intervention will involve therapist-guided, interactive virtual exercises in a shared environment, promoting real-time engagement and feedback. The NIVR group will perform task-oriented exercises using screen-based virtual reality without immersive and collaborative features. Both interventions will be delivered over an 12-week period. Primary outcomes will assess motor function using standardized clinical scales, while secondary outcomes will evaluate cognitive function, mobility, and quality of life. The study seeks to determine whether collaborative and interactive virtual rehabilitation provides superior clinical outcomes compared to conventional non-immersive virtual approaches in patients with Parkinson's disease.

Key facts

Study ID

NCT07523425

Run by

Superior University

People needed

60

Starts

2025-05-27

Expected to finish

2026-09-30

Last updated by the study team

2026-04-15

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and Female
• Age: 45 years-80 Years
• Diagnosed patients of idiopathic Parkinson Disease with minor to moderate severity according to the Hoehn \& Yahr stages I-III.
• On conventional and stable medical treatment at present
• No severe cognitive impairments (MMSE ≥ 24).
• Ability to participate in virtual rehabilitation sessions
• Willingness to participate and provide informed consent

You may not qualify if…

• Severe visual, auditory, or motor impairments unrelated to Parkinson's.
• Fear of virtual environment.
• Comorbidities that hinder participation in the treatment (e.g., advanced dementia).
• Severe musculoskeletal conditions limiting movement
• History of epilepsy or conditions contraindicating virtual reality exposure
• Participation in another interventional study within the last 3 months

Where it is running

• Punjab Institute of Neurosciences Lahore — Lahore, Punjab Province, Pakistan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.